Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-25

FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for the fixed-dose combination of chlordiazepoxide hydrochloride and clidinium bromide (Librax) from Ascend Laborato…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LIBRAX (Chlordiazepoxide hydrochloride and clidinium bromide)

Snippet

SUPPL AP for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE (CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE)